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Abstract 
Background: Multiple sclerosis is increasingly becoming a major health problem among women worldwide. The aim 
of the present study was to estimate prevalence of depression in women with multiple sclerosis and also to identify 
risk factors contributing to its development.
Methods: This was a cross-sectional study of depression in a sample of 226 women with multiple sclerosis. The 
sample was recruited from an outpatient clinic in Tehran, Iran. Depression was assessed using the Beck Depression 
Inventory-II (BDI-II). Univariate and multiple logistic regression analyses were performed to examine the association 
between depression and independent variables.
Results: Overall, 91 women (40.2 %) had moderate to severe depression. The mean age of participants was 35.7 years 
(SD = 8.07). The results obtained from multiple logistic regression analysis showed that the disease course (OR for 
relapsing–remitting MS = 2.36, % 95 CI = 1.14–5.53, P = 0.46), the expanded disability status scale (OR for score of 
5–8 = 4.88, % 95 CI = 2.51–11.06, P < 0.001) and employment status (OR for housewife = 4.75, % 95 CI = 1.55–14.58, 
P = 0.006) were significant contributing factors to depression in patients with multiple sclerosis.
Conclusions: The findings suggest that depression in patients with multiple sclerosis is multi-factorial and very much 
dependent to physical and social conditions of patients. The recognition of such conditions might help clinicians to 
manage patients more effectively.
© 2015 Mohammadi et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International 
License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any 
medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons 
license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.
org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Multiple sclerosis (MS) is a chronic and functional disa-
bling disease, occurring from demyelination of the CNS 
nerve fibers [1]. During the last decade there was dra-
matic increase in the incidence and prevalence of MS 
in Iranian population and it was reported that female/
male ratio ranged from 1.8 to 3.6 [2, 3]. Similarly a west-
ern study found that the real increased incidence was 
limited to women [4]. A recent study suggested that the 
prevalence of MS in Iran is even higher than neighboring 
countries and within Iran itself the prevalence varies by 
geographical areas. One can speculate that genetic and 
environmental factors might have contributed to these 
observations [3]. It is well documented that one of the 
environmental risk factors for developing MS is vitamin 
D insufficiency [5]. On the other hand, there is increas-
ing evidences for the vitamin D deficiency among Iranian 
women [6–8].
The disease has several adverse effects on patients’ life. 
Patients with multiple sclerosis not only suffer from phys-
ical disability but also experience psychological distress 
more often. Depressive disorders are more prevalent in 
MS patients compared to other chronic neurologic dis-
orders [9]. Thus, depression is often underreported and 
under-diagnosed in patients with multiple sclerosis.
In a study from Portugal, Silva et  al. found that there 
were significant associations between depression and 
several factors including age, disease duration, age at 
onset, and functional impairment in MS patients [10].
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Chwastiak and Ehde summarized the literature and 
suggested that depression in MS patients may contribute 
to cognitive dysfunction, decreased quality of life, unem-
ployment, and decreased adherent to treatment regimens 
for MS compared to non-depressed MS patients [11]. 
Furthermore, it was shown that MS patients with depres-
sion develop fatigue about four times more than non-
depressed MS patients [12]. It remains unclear whether a 
secondary response to the illness is the reason of depres-
sion or the neurobiological effects are the origins of 
depression [10].
It is crucial for the health care providers to have a better 
understanding about the identification of patients who 
are at risk of developing depression in this community. 
However, if risk factors for depression identified, it may 
lead to the timely initiation of appropriate treatment and 
to produce efficient strategies to lowering MS burden as 
soon as possible. To the best of our knowledge, there are 
a few studies about depression in MS patients in Iran. A 
study of 106 MS patients indicated that physical disability 
and depression strongly influenced quality of life in these 
patients [13]. Another investigation from Iran showed 
that depression in MS patients might cause fatigue and 
sleep disturbances [14]. However, none of these studies 
indicated risk factors for depression in MS patients. The 
aim of the present study was to estimate prevalence of 
depression in Iranian women with MS and also to iden-
tify risk factors that contribute to its development.
Methods
Design and procedure
This was a cross-sectional study that carried out to assess 
depression in female patients with multiple sclerosis. A 
detailed design is explained elsewhere [15] but in sum-
mary a total of two hundred and twenty-six female 
patients with multiple sclerosis were recruited consecu-
tively from an MS outpatient clinic in Tehran, Iran. Cri-
teria for inclusion were: diagnosis of MS according to the 
McDonald Revised criteria [16], be married; having the 
Expanded Disability Status Scale (EDSS) score ≤  8 [17] 
and willingness to participate in the study. It is worth 
noting that the current study was as part of an investi-
gation on sexual dysfunction in women with multiple 
sclerosis. Since for Muslims sexual function out of mar-
riage is forbidden we only studied married women. 
Women with pre-existing major chronic illnesses such as 
depression were excluded. All patients had a neurologic 
examination.
Measures
1. Sociodemographic and clinical characteristic 
included recording of age, education, employment 
status, age at onset of disease, disease duration, dis-
ease course, and degree of disability. This latter infor-
mation was collected by using the Kutzke Expanded 
Disability Status Scale (EDSS). In fact, the EDSS 
assesses the neurological impairment in women with 
MS patients [17]. The score on the EDSS ranges from 
1 to 10. Scores from 1.0 to 4.5 specify that patients 
are fully ambulatory while scores from 5.0 to 9.5 indi-
cate that patients are severely impaired and death 
defines a score of 10.
2. Depression: The Beck Depression Inventory-II (BDI-
II) was used to assess the presence and intensity of 
depressive symptoms [18, 19]. This instrument con-
sists of 21 items. Each item is rated on a 4-point Lik-
ert scale ranging from 0 to 3 and thus giving a total 
score of 0–63, with higher scores indicating more 
frequent depression symptoms. A cutoff point of 19 
and higher was considered as moderate to severe 
depression [20]. Psychometric properties of the Ira-
nian version of the BDI-II are well documented [21].
Analysis
Descriptive statistics was used to explore the data. Par-
ticipants were classified as with and without depression 
based on the Beck Depression Inventory-II (BDI-II). Uni-
variate analysis was performed to indicate the association 
between dependent (depression) and independent vari-
ables. Then, to determine the risk factors for depression 
in MS patients, multiple logistic regression analysis was 
carried out while controlling for all independent vari-
ables. The reference level for age was age < 35 years old 
versus aged 35  years old and older; for education was 
higher level versus primary/secondary level; for employ-
ment status was employed versus not employed; for dis-
ease duration was 0–8 years versus ≥ 9 years; for disease 
course was RRMS versus PPMS/SPMS; for EDSS was 
score 0–4.5 versus 5–8; and for depression treatment was 
yes versus no. The SPSS version 16 was used to analyze 
the data in two steps.
Ethics
The ethics committee of Shahed University approved the 
study. We obtained written informed consent from par-
ticipants after comprehensive explanation of procedure 
involved.
Results
Sociodemographic and clinical characteristics of the study 
sample
In all 226 women with multiple sclerosis were studied. 
The mean age of participants was 35.7 years (SD = 8.07). 
The mean disease duration and age at onset of the disease 
were 1.84 (SD = 0.79) and 29.51(SD = 7.65) years, respec-
tively. The mean depression severity score (BDI) was 17.86 
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(SD  =  11.13). The disease course was as follows: 169 of 
patients (74.8  %) had relapsing–remitting MS (RRMS), 
4 (1.8  %) had primary progressive MS (PPMS) and 53 
(23.5  %) had secondary progressive MS (SPMS). There 
were 165 patients (73.0 %) with the EDSS score less than 
4.5. One hundred and fifty-seven patients (69.5 %) had low 
educational levels and 189 patients (83.6  %) were house-
wife. Overall, 91 women (40.2 %) had moderate to severe 
depression. The detailed results are shown in Table 1.
The EDSS score for RRMS and PPMS/SPMS is shown 
in Table  2. As shown, most patients with RRMS scored 
0–4.5 while a small number for patients with PPMS/
SPMS scored 0–4.5 (86 vs. 35 %).
Risk factors for depression
The association between depression and independent 
variables was first examined by univariate analysis. The 
results showed that there were significant associations 
between depression and the disease duration (P = 0.050), 
the EDSS (P < 0.001), educational level (P = 0.046) and 
employment status (P  <  0.001). However, no signifi-
cant associations observed between depression and age 
(P = 0.567), the disease course (P = 0.522), age at onset 
of the disease (P  =  0.225) and depression treatment 
(P = 0.713). The results are shown in Table 1.
As shown in Table  3 the results obtained from mul-
tiple logistic regression analysis indicated that the dis-
ease course (OR for relapsing–remitting MS  =  2.36, 
%  95 CI  =  1.14–5.53, P  =  0.46), EDSS (OR for score 
of 5–8  =  4.88, %  95 CI  =  2.51–11.06, P  <  0.001) and 
employment status (OR for housewife  =  4.75, %  95 
CI  =  1.55–14.58, P  =  0.006) were significant contrib-
uting factors to depression in patients with multiple 
sclerosis.
Discussion
The findings from current study showed that the preva-
lence of depression among Iranian female with MS was 
relatively high. As suggested this high prevalence might 
be explained by various reasons including structural 
brain damage [22], physical disability [23], treatment 
medication [24], and severity of MS. Unfortunately, it 
was reported that two-thirds of depressed MS patients 
receive no treatment [25].
Table 1 Characteristics of the study sample
a Derived from univariate logistic regression analysis
b In fact, these patients were indicated as ‘without depression’ based on cutoff value of the Beck Depression Inventory; otherwise clinicians recognized these patients 
as having depression and thus received treatment
With depression (n = 91) Without depression (n = 125) OR (95 % CI)a P
No. (%) No. (%)
Age (years)
 ≤35 45 (49.5) 72 (53.3) 1.0 (ref.)
 >35 46 (50.5) 63 (46.7) 1.16 (0.68–1.98) 0.567
Education
 Higher 21 (23.1) 48 (35.6) 1.0 (ref.)
 Primary/secondary 70 (76.9) 87 (64.4) 1.83 (1.00-3.35) 0.046
Employment status
 Employed 5 (5.5) 103 (76.3) 1.0 (ref.)
 House wife 86 (94.5) 32 (23.7) 5.34 (1.99–14.31) <0.001
Age at onset of disease (mean/SD) 28.75 (7.71) 30.02 (7.60) 0.97 (0.94–1.01) 0.225
Disease duration (years)
 0–8 62 (68.1) 107 (79.3) 1.0 (ref.)
 ≥ 9 29 (31.9) 28 (20.7) 1.78 (0.97-3.27) 0.050
Disease course
 RRMS 66 (72.5) 103 (76.3) 1.0 (ref.)
 PPMS and SPMS 25 (27.5) 32 (23.7) 0.82 (0.44–1.50) 0.522
EDSS score
 0–4.5 52 (57.1) 113 (83.7) 1.0 (ref.)
 5–8 39 (42.9) 22 (16.2) 3.85 (2.07–7.14) < 0.001
Received treatment for depression
 Yes 7 (7.7) 15b (11.1) 1.0 (ref.)
 No 84 (92.3) 120 (88.9) 0.66 (0.26–1.70) 0.398
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Physical disability considered as common MS conse-
quence that may be associated with depression in this 
community. However, the relationship between physical 
disability and depression in MS patients remains con-
troversial [26]. Perhaps assessing link between depres-
sion and physical disability in MS patients needs a cohort 
design. However, unlike the results of studies that did 
not find any association between physical disability and 
depression in MS patients [27, 28] the current study 
showed that functional impairment was a significant 
contributing factor to the outcome. It seems that the 
depression worsens as the disease progresses. On the 
other hand, consistent with our study, Chwastiak et  al. 
reported that MS patients with advanced disability were 
six times more likely to experience depressive symptoms 
than those reporting minimal severity [29]. One pos-
sible explanation is that the physical problems might be 
impeding participation in recreational activities and also 
it was associated with occupational problems [30]. The 
result of study revealed that disability in patients with 
multiple sclerosis is age dependent. It is argued that the 
disability milestone was reached at about the same age in 
different courses of disease [31]. It might be explained by 
the fact that in this study the patients with RRMS were 
older than PPMS/SPMS.
The effect of unemployment has not been suitably 
investigated in MS patients. This study showed that 189 
women (83.6  %) with MS were unemployed. This high 
unemployment status in MS patients might be explained 
by different variables including neurological, cognitive 
status, anxiety and depression [32]. Overall women’s 
unemployment rate is 20.9  % according to the latest 
report released by the Statistical Center of Iran [33].
We found that women with RRMS experienced higher 
rate of depression compared with women at progressive 
stage. Similarly, Zabad et al. found that patients with pri-
mary progressive MS had a lower lifetime risk of major 
depression compared with patients with relapsing forms 
of the disease. It was suggested that perhaps the PPMS 
group might have received more adequate social support, 
which may have conferred a protective effect for depres-
sion occurrence in these patients. In addition, increased 
inflammatory components were reported in the relaps-
ing forms of MS that may be associated with depression 
[34]. However, the association between the course of dis-
ease and depression was found to be inconsistent when 
relapsing–remitting MS was compared with progres-
sive MS [35]. Other investigators found that depression 
symptoms were persistent even during remission from 
MS [36, 37]. There is evidence that 85 % of MS patients 
who were diagnosed with RR experienced a stressful life 
event. Accordingly, it could be argued that a higher rate 
of anxiety and depression among this group of patients 
might be associated with worse adjustment problems [38, 
39].
Limitations
The findings from this study should be interpreted with 
caution since the study had some limitations. This was 
a cross-sectional study while longitudinal studies are 
needed to establish link between depression and multi-
ple sclerosis. It is argued that depression in this patient 
might be due to several reasons including the fact that it 
Table 2 EDSS scores of RRMS versus PPMS and SPMS groups
* P value for mean difference = 0.095
RRMS PPMS/SPMS
No. (%) No. (%)
EDSS score
 0–4.5 145 (86) 20 (35)
 5–8 24 (14.4) 37 (65)
 Mean (SD)* 2.20 (0.16) 2.08 (0.27)
Table 3 The results obtained from  multiple logistic 
regression analysis indicating risk factors for  depression 
(n = 226)
OR (95 % CI) P
Age (years)
>35 1.0 (ref.)
 ≤35 1.03 (0.54–1.97) 0.908
Education
 Higher 1.0 (ref.)
 Primary/secondary 1.09 (0.51–2.3) 0.815
Employment status
 Employed 1.0 (ref.)
 House wife 4.75 (1.55–14.58) 0.006
Disease duration (years)
 0–8 1.0 (ref.)
 ≥ 9 1.34 (0.65–2.76) 0.420
Disease course
 RRMS 1.0 (ref.)
 PPMS and SPMS 0.42 (0.18–0.98) 0.046
EDSS score
 0–4.5 1.0 (ref.)
 5–8 4.88 (2.15–11.06) < 0.001
Age at onset of the disease 0.96 (0.93–1.00) 0.115
Depression treatment
 Yes 1.0 (ref.)
 No 1.21 (0.43–3.33) 0.713
2 log-likelihood test 267.24
Nagelkerke R2 0.206
Global percentage of identified cases 69.5
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may precede the onset of the disorder (being a risk fac-
tor for actions on immune system), may be a reaction to 
the disease (principally, as adjustment disorder), may be a 
consequence of the therapy (interferon, for example) and 
may depend on brain lesions caused by the disease.
Conclusion
The findings indicated that depression was frequent in 
women with multiple sclerosis. Identifying factors associ-
ated to depression in MS patients is important because 
this may allow clinicians to address some potentially 
reversible causes or manage patients more efficiently at 
earlier time.
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